-
Use of thiopurines in inflammatory bowel disease: an update
- Arshdeep Singh
 , Ramit Mahajan, Saurabh Kedia, et al.
-
Intest Res. 2022;20(1):11-30.
-
Review
Epub April 15, 2021
|
-
Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
- Sang Hyoung Park
-
Intest Res. 2022;20(2):159-164.
-
Review
Epub April 29, 2022
|
-
Natural history of inflammatory bowel disease: a comparison between the East and the West
- Eun Mi Song, Suk-Kyun Yang
-
Intest Res. 2022;20(4):418-430.
-
Review
Epub December 2, 2021
|
-
The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment
- Sang Hoon Kim, Yun Jeong Lim
-
Intest Res. 2022;20(1):31-42.
-
Review
Epub May 21, 2021
|
-
Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy
- Danny Con
 , Bridgette Andrew, Steven Nicolaides, et al.
-
Intest Res. 2022;20(1):101-113.
-
Original Article
Epub March 12, 2021
|
-
Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
- Soo-Young Na, Chang Hwan Choi, Eun Mi Song, et al.
-
Intest Res. 2023;21(1):61-87.
-
Review
Epub May 31, 2022
|
-
Management of inflammatory bowel disease in the COVID-19 era
- Kyeong Ok Kim, Byung Ik Jang
-
Intest Res. 2022;20(1):3-10.
-
Review
Epub February 3, 2021
|
-
Endoscopic diagnosis and treatment of early colorectal cancer
- Seung Wook Hong, Jeong-Sik Byeon
-
Intest Res. 2022;20(3):281-290.
-
Review
Epub July 26, 2022
|
-
Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease
- Seong-Joon Koh, Sung Noh Hong, Soo-Kyung Park, et al.
-
Intest Res. 2023;21(1):43-60.
-
Review
Epub October 18, 2022
|
-
Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
- Anupam K. Singh, Anuraag Jena, Praveen Kumar-M, et al.
-
Intest Res. 2022;20(1):134-143.
-
Original Article
Epub January 18, 2021
|
-
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
- Seung Yong Shin, Soo Jung Park, Young Kim, et al.
-
Intest Res. 2022;20(3):350-360.
-
Original Article
Epub July 23, 2021
|
-
The dietary practices and beliefs of British South Asian people living with inflammatory bowel disease: a multicenter study from the United Kingdom
- Benjamin Crooks
 , Ravi Misra, Naila Arebi, et al.
-
Intest Res. 2022;20(1):53-63.
-
Original Article
Epub January 6, 2021
|
-
An integrative review of physical activity in adults with inflammatory bowel disease
- Suja P Davis
 , Patricia B. Crane, Linda P. Bolin, et al.
-
Intest Res. 2022;20(1):43-52.
-
Review
Epub January 22, 2021
|
-
Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
- Vitaliy Y. Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, et al.
-
Intest Res. 2022;20(1):72-77.
-
Original Article
Epub February 3, 2021
|
-
Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease
- Shigeki Bamba
 , Osamu Inatomi, Atsushi Nishida, et al.
-
Intest Res. 2022;20(3):370-380.
-
Original Article
Epub May 14, 2021
|
-
Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation
- Brigida Barberio
 , Edoardo Vincenzo Savarino, Timothy Card, et al.
-
Intest Res. 2022;20(1):114-123.
-
Original Article
Epub August 4, 2021
|
-
Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
- Ramit Mahajan, Arshdeep Singh, Saurabh Kedia, et al.
-
Intest Res. 2022;20(1):64-71.
-
Original Article
Epub February 3, 2021
|
-
Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
- Fares Ayoub, Matthew Odenwald, Dejan Micic, et al.
-
Intest Res. 2022;20(2):240-250.
-
Original Article
Epub February 8, 2022
|
-
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
- Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, et al.
-
Intest Res. 2023;21(1):110-125.
-
Original Article
Epub March 11, 2022
|
-
Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease
- Seung Yong Shin, Young Kim, Won-Seok Kim, et al.
-
Intest Res. 2023;21(1):148-160.
-
Original Article
Epub June 14, 2022
|
-
Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity
- Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, et al.
-
Intest Res. 2022;20(1):90-100.
-
Original Article
Epub January 22, 2021
|
-
An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia
- Nor Hamizah Shafiee
 , Nurul Huda Razalli, Norfilza M. Mokhtar, et al.
-
Intest Res. 2022;20(1):124-133.
-
Original Article
Epub January 22, 2021
|
-
Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease
- Anthony Buisson, Lisa Cannon, Konstantin Umanskiy, et al.
-
Intest Res. 2022;20(3):303-312.
-
Original Article
Epub August 4, 2021
|
-
Landscape of inflammatory bowel disease in Singapore
- Daren Low
 , Nidhi Swarup, Toshiyuki Okada, et al.
-
Intest Res. 2022;20(3):291-296.
-
Review
Epub January 7, 2022
|
-
Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease
- Meng-Tzu Weng
 , I-Lun Shih, Chien-Chih Tung, et al.
-
Intest Res. 2022;20(2):224-230.
-
Original Article
Epub February 8, 2022
|
-
One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study
- Yuichi Matsuno, Takehiro Torisu, Junji Umeno, et al.
-
Intest Res. 2022;20(2):260-268.
-
Original Article
Epub April 29, 2022
|
-
Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study
- Kensuke Sakurai, Shigeru Furukawa, Takehiko Katsurada, et al.
-
Intest Res. 2022;20(1):78-89.
-
Original Article
Epub January 22, 2021
|
-
An Asian perspective on irritable bowel syndrome
- Kee Wook Jung, Seung-Jae Myung
-
Intest Res. 2023;21(2):189-195.
-
Review
Epub May 31, 2022
|
-
A case of autoimmune enteropathy with CTLA4 haploinsufficiency
- Haruka Miyazaki, Namiko Hoshi, Michitaka Kohashi, et al.
-
Intest Res. 2022;20(1):144-149.
-
Case Report
Epub January 22, 2021
|
-
SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID
- Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, et al.
-
Intest Res. 2022;20(2):171-183.
-
Statement
Epub January 5, 2022
|
